Levetiracetam improves learning and memory in people with Alzheimer’s disease and epilepsy

12 Oct 2021

Levetiracetam has been found to improve cognitive functions, like learning and memory, in people diagnosed with Alzheimer’s disease who also have epileptic brain activity, a study in Journal of the American Medical Association (JAMA) Neurology has found.

There are around 850,000 people with dementia in the UK. Alzheimer’s disease is a particular type of dementia. It affects between half and three-quarters (50-75%) of people with dementia, according to the Alzheimer’s Society.

According to the study, among people with Alzheimer’s disease, up to around three in five (60%) have seizures or silent epileptic activity in the brain. This means that epileptic activity shows up in tests, but there are no visible signs of a seizure in the person.

Lead study author Dr Keith Vossel called Alzheimer’s disease with epileptic activity an “epileptic variant” of the disease.

The study analysed 34 people with Alzheimer’s disease, of whom two-fifths (40%) had epileptic activity. People were split up into two groups, and received treatment with a dummy medicine or a low dose of levetiracetam for four weeks. This was alongside their current Alzheimer’s disease treatment. Then, the groups had a four-week break and swapped over to receive the opposite treatment.

The researchers assessed people’s abilities to problem solve, reason, remember words and navigate during treatment. People treated with levetiracetam showed a tendency towards improvement in these kinds of skills. People with silent epileptic activity were seen to have a clear benefit of this medicine to their cognitive functions.

The researchers concluded that these findings showed the importance of extended neurology assessments in Alzheimer’s disease patients, to identify people with epileptic activity who may benefit from levetiracetam.

The full study is available on the JAMA Neurology website.


You may also be interested in...

Partnership aims to establish research priorities for epilepsy

A group of epilepsy charities, clinicians, researchers and people with epilepsy have joined forces to identify which areas of epilepsy need to be prioritised for research.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.